Logo image of CTM.CA

CANTERRA MINERALS CORP (CTM.CA) Stock Fundamental Analysis

TSX-V:CTM - CA1381342007 - Common Stock

0.125 CAD
+0.03 (+31.58%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

3

CTM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 803 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for CTM as it has an excellent financial health rating, but there are worries on the profitability. CTM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CTM had negative earnings in the past year.
In the past year CTM has reported a negative cash flow from operations.
CTM had negative earnings in each of the past 5 years.
In the past 5 years CTM always reported negative operating cash flow.
CTM.CA Yearly Net Income VS EBIT VS OCF VS FCFCTM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

With a Return On Assets value of -13.78%, CTM perfoms like the industry average, outperforming 56.16% of the companies in the same industry.
With a decent Return On Equity value of -14.57%, CTM is doing good in the industry, outperforming 60.15% of the companies in the same industry.
Industry RankSector Rank
ROA -13.78%
ROE -14.57%
ROIC N/A
ROA(3y)-30.77%
ROA(5y)-31.98%
ROE(3y)-36.11%
ROE(5y)-35.9%
ROIC(3y)N/A
ROIC(5y)N/A
CTM.CA Yearly ROA, ROE, ROICCTM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTM.CA Yearly Profit, Operating, Gross MarginsCTM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

CTM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CTM has been increased compared to 5 years ago.
CTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTM.CA Yearly Shares OutstandingCTM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CTM.CA Yearly Total Debt VS Total AssetsCTM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

CTM has an Altman-Z score of 15.08. This indicates that CTM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CTM (15.08) is better than 74.97% of its industry peers.
There is no outstanding debt for CTM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.08
ROIC/WACCN/A
WACCN/A
CTM.CA Yearly LT Debt VS Equity VS FCFCTM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

CTM has a Current Ratio of 4.38. This indicates that CTM is financially healthy and has no problem in meeting its short term obligations.
CTM's Current ratio of 4.38 is fine compared to the rest of the industry. CTM outperforms 71.98% of its industry peers.
A Quick Ratio of 4.38 indicates that CTM has no problem at all paying its short term obligations.
The Quick ratio of CTM (4.38) is better than 72.35% of its industry peers.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 4.38
CTM.CA Yearly Current Assets VS Current LiabilitesCTM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

CTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.47%, which is quite impressive.
EPS 1Y (TTM)35.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTM.CA Price Earnings VS Forward Price EarningsCTM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTM.CA Per share dataCTM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANTERRA MINERALS CORP

TSX-V:CTM (8/29/2025, 7:00:00 PM)

0.125

+0.03 (+31.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-25 2025-11-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap42.91M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.22
P/tB 2.22
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.78%
ROE -14.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.77%
ROA(5y)-31.98%
ROE(3y)-36.11%
ROE(5y)-35.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.38
Quick Ratio 4.38
Altman-Z 15.08
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-70.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.35%
OCF growth 3YN/A
OCF growth 5YN/A